Live Breaking News & Updates on Iteos Therapeutics

Stay updated with breaking news from Iteos therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Head to Head Contrast: Caribou Biosciences (NASDAQ:CRBU) versus iTeos Therapeutics (NASDAQ:ITOS)

ITeos Therapeutics (NASDAQ:ITOS – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations. Profitability This table compares iTeos Therapeutics and […] ....

United States , Iteos Therapeutics Inc , Caribou Biosciences Inc , Teos Therapeutics , Get Free Report , Caribou Biosciences , Caribou Bioscience , Given Caribou Bioscience , Teos Therapeutics Daily , Iteos Therapeutics , Nasdaq Itos , Stock Comparison , Stock Analysis ,

Comparing iTeos Therapeutics (NASDAQ:ITOS) & Inhibrx (NASDAQ:INBX)

ITeos Therapeutics (NASDAQ:ITOS – Get Free Report) and Inhibrx (NASDAQ:INBX – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation. Analyst Recommendations This is a breakdown of recent […] ....

United States , La Jolla , Chiesi Farmaceutici , Iteos Therapeutics Inc , Inhibrx Inc , Bristol Myers Squibb Company , Teos Therapeutics , Get Free Report , Teos Therapeutic , Teos Therapeutics Daily , Iteos Therapeutics , Nasdaq Itos , Stock Comparison , Stock Analysis ,

iTeos Therapeutics, Inc. to Post FY2023 Earnings of ($3.84) Per Share, HC Wainwright Forecasts (NASDAQ:ITOS)

ITeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Equities research analysts at HC Wainwright boosted their FY2023 EPS estimates for iTeos Therapeutics in a research report issued to clients and investors on Wednesday, November 8th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($3.84) per share for the year, […] ....

Boxer Capital Llc , Swiss National Bank , Metlife Investment Management , Jpmorgan Chase Co , Iteos Therapeutics Inc , Teos Therapeutics Company Profile , Securities Exchange Commission , Teos Therapeutics Inc , York Mellon Corp , Teos Therapeutics , Free Report , Teos Therapeutic , National Bank , New York Mellon Corp , Life Investment Management , Rhumbline Advisers , Boxer Capital , Exchange Commission , Teos Therapeutics Company , Get Free Report , Teos Therapeutics Daily , Iteos Therapeutics , Nasdaq Itos , Earnings Estimates , Hc Wainwright ,

iTeos Therapeutics, Inc. (NASDAQ:ITOS) Insider Sells $5,691,000.00 in Stock

ITeos Therapeutics, Inc. (NASDAQ:ITOS – Get Free Report) insider Boxer Capital, Llc sold 350,000 shares of the company’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $16.26, for a total value of $5,691,000.00. Following the sale, the insider now owns 1,804,058 shares in the company, valued […] ....

Hong Kong , Securities Exchange Commission , Teos Therapeutics Inc , Teos Therapeutics Company Profile , Royal Bank , Quadrant Capital Group , Boxer Capital Llc , Hong Kong Ltd , Cm Bidwell Associates Ltd , James Investment Research Inc , Iteos Therapeutics Inc , Teos Therapeutics , Get Free Report , Boxer Capital , Exchange Commission , Teos Therapeutics Trading Down , Capital Group , Investment Research , Kong Ltd , Teos Therapeutics Company , Teos Therapeutics Daily , Iteos Therapeutics , Nasdaq Itos , Insider Trading , Nsider Trades ,

How Roche's Accidental Update Lifted An Entire Group Of Stocks

Accidentally published positive interim results from a lung cancer treatment study on Wednesday, and helped boost not only Roche stock, but shares of smaller… ....

Iteos Therapeutics , Arcus Biosciences , Reaking News ,